Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil in Pulmonary Arterial Hypertension (SUPER-1)
NCT00644605Phase 3Completed
- Sponsor
- Viatris
- Start
- Oct 2002
- Countries
- 23
01
Overview
A Phase 3 trial of ASP-001 in pulmonary arterial hypertension (PAH), sponsored by Viatris. Started Oct 2002; status: completed.
02
Drugs
ASP-001
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT00644605.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00644605.